Figure 2 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 4 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 1 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 6 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 5 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 7 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 3 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Additional file 1 of Short-term oral zinc supplementation enhances Natural Killer cell functionality and decreases circulating Innate Lymphoid Cell counts and frequencies in health... by Lara Amling (20882028)

Table 1_MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells.xlsx by Rowan Abdelbary (20589248)

“…In hepatocellular carcinoma (HCC) specifically, a reduction in the number and efficiency of circulating and intrahepatic natural killer (NK) cells has been reported. …”

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Table 2_Transcriptomic and proteomic signatures of host NK cells delineate distinct immune states across tuberculosis infection statuses.xlsx by Han Zhang (110653)

“…Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. …”

Table 4_Transcriptomic and proteomic signatures of host NK cells delineate distinct immune states across tuberculosis infection statuses.xlsx by Han Zhang (110653)

“…Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. …”

Data Sheet 2_Transcriptomic and proteomic signatures of host NK cells delineate distinct immune states across tuberculosis infection statuses.pdf by Han Zhang (110653)

“…Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. …”

Table 3_Transcriptomic and proteomic signatures of host NK cells delineate distinct immune states across tuberculosis infection statuses.xlsx by Han Zhang (110653)

“…Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. …”

Table 5_Transcriptomic and proteomic signatures of host NK cells delineate distinct immune states across tuberculosis infection statuses.xlsx by Han Zhang (110653)

“…Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. …”

Data Sheet 1_Transcriptomic and proteomic signatures of host NK cells delineate distinct immune states across tuberculosis infection statuses.pdf by Han Zhang (110653)

“…Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. …”

Table 1_Transcriptomic and proteomic signatures of host NK cells delineate distinct immune states across tuberculosis infection statuses.xlsx by Han Zhang (110653)

“…Moreover, analysis of ATB-specific chemotaxis genes suggested that the migration of NK cells was likely to occur in the ATB state. Flow cytometry revealed an increased frequency of CD56dim NK cells and a decreased frequency of CD56bright NK cells in individuals with LTBI versus that in HCs in an independent cohort. …”

Table 2_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.xlsx by Lillia A. Baird (10575941)

“…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”

Table 1_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.xlsx by Lillia A. Baird (10575941)

“…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”

Data Sheet 1_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.docx by Lillia A. Baird (10575941)

“…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”